PSA Screening Reduces Deaths From Prostate Cancer, Study Finds

Routine tests used to detect prostate cancer reduce the risk of death from the disease, researchers said, adding more evidence to a debate over the role of screening.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.